Correlation Between Lyra Therapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and Corvus Pharmaceuticals
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyra and Corvus is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Corvus Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Corvus Pharmaceuticals. In addition to that, Lyra Therapeutics is 1.04 times more volatile than Corvus Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest 77.00 in Corvus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 748.00 from holding Corvus Pharmaceuticals or generate 971.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Lyra Therapeutics |
| Corvus Pharmaceuticals |
Lyra Therapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |